ANAPC1 | Anaphase promoting complex subunit 1 | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
ANKLE1 | Ankyrin repeat and LEM domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ANKLE2 | Ankyrin repeat and LEM domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANKRD29 | Ankyrin repeat domain 29 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANKRD32 | Ankyrin repeat domain 32 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ANKRD46 | Ankyrin repeat domain 46 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANTXR1 | Anthrax toxin receptor 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ANTXRL | Anthrax toxin receptor-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
AP000322.53 | | Predicted membrane proteins
| | | | | Group enriched |
AP5S1 | Adaptor-related protein complex 5, sigma 1 subunit | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APCDD1 | Adenomatosis polyposis coli down-regulated 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APCDD1L | Adenomatosis polyposis coli down-regulated 1-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APMAP | Adipocyte plasma membrane associated protein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL4 | Apolipoprotein L, 4 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
APOO | Apolipoprotein O | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AREG | Amphiregulin | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
AREL1 | Apoptosis resistant E3 ubiquitin protein ligase 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP26 | Rho GTPase activating protein 26 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARL10 | ADP-ribosylation factor-like 10 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
ARMC10 | Armadillo repeat containing 10 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARMCX1 | Armadillo repeat containing, X-linked 1 | Predicted membrane proteins
| | | | | Expressed in all |
ARMCX2 | Armadillo repeat containing, X-linked 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ARMCX3 | Armadillo repeat containing, X-linked 3 | Predicted membrane proteins
| | | | | Expressed in all |
ARMCX6 | Armadillo repeat containing, X-linked 6 | Predicted membrane proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ART1 | ADP-ribosyltransferase 1 | CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASB11 | Ankyrin repeat and SOCS box containing 11, E3 ubiquitin protein ligase | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ASB18 | Ankyrin repeat and SOCS box containing 18 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ASB5 | Ankyrin repeat and SOCS box containing 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASIC1 | Acid-sensing (proton-gated) ion channel 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ASIC3 | Acid-sensing (proton-gated) ion channel 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASPHD2 | Aspartate beta-hydroxylase domain containing 2 | Predicted membrane proteins
| | | | | Mixed |
ASPRV1 | Aspartic peptidase, retroviral-like 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASTN2 | Astrotactin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASZ1 | Ankyrin repeat, SAM and basic leucine zipper domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |